The Eindhoven startup Salvia BioElectronics B.V. has received additional investment from the Brabant Startup Fund (BSF), bringing the total seed funding to €3.1 million. The startup already received investment from the Brabant Development Agency (BOM) and Thuja Capital, which is complemented with a loan from the Netherlands Enterprise Agency (RVO). At the High Tech Campus Eindhoven, Salvia develops a minimally invasive bioelectronics solution for people suffering from chronic neurological disease.

Hubert Martens, CEO of Salvia BioElectronics, noted: “We are very pleased to attract this additional funding that allows us to further mature our technology before initiating the product development phase. This will translate in a substantial acceleration of the product development phase after the upcoming series-A funding round.” Gerard Spanbroek, director of the Brabant Startup Funded added: “The BSF supports early-stage innovative companies with a strong growth potential. We are keen on supporting Salvia towards their next growth phase. We are impressed by the progress that this experienced team realized in a short amount of time and see significant potential health benefits of their novel product concept.”

Read more about Salvia BioElectronics here

Become a member!

On Innovation Origins you can read the latest news about the world of innovation every day. We want to keep it that way, but we can't do it alone! Are you enjoying our articles and would you like to support independent journalism? Become a member and read our stories guaranteed ad-free.

About the author

Author profile picture Frans van Beveren leads IO on a daily basis. He is fascinated by everything related to technical progress, innovation, sustainability, and industrial design.